CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Enovis Corp is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Enovis Corp
2711 CENTERVILLE ROAD, SUITE 400
Phone: (302) 252-9160p:302 252-9160 WILMINGTON, DE  19808  United States Ticker: ENOVENOV

Business Summary
Enovis Corporation is a medical technology company. It is focused on developing clinically differentiated solutions by manufacturing and distributing medical devices with a range of products used for reconstructive surgery, rehabilitation, pain management and physical therapy. It operates through two segments: Prevention & Recovery and Reconstructive. The Prevention & Recovery segment develops, manufactures, and distributes rigid bracing products, orthopedic soft goods, vascular systems and compression garments, and hot and cold therapy products and offers recovery sciences products in the clinical rehabilitation and sports medicine markets, such as bone growth stimulators and electrical stimulators used for pain management. The Reconstructive segment develops, manufactures, and markets a variety of knee, hip, shoulder, elbow, foot, ankle, and finger implant products and surgical productivity tools. It also provides Novastep, a minimally invasive surgery (MIS) foot and ankle solutions.
(Source: 10-K)

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
YesYes-YesYes--

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
12/31/202312/31/2023YesYes--Yes

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Chairman of the Board, Chief Executive Officer Matthew L.Trerotola 55 5/16/2023 7/24/2015
Director Brady R.Shirley 57 4/1/2024 11/1/2016
Chief Financial Officer, Executive Vice President Phillip B.Berry 44 1/1/2023 1/1/2023
10 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
ESAB India Ltd 13, 3rd Main Road,, Industrial Estate, AMBATTUR India
ESAB NEDERLAND B.V. POSTBUS 2236 AMERSFOORT
Mathys AG Bettlach Robert Mathys Strasse 5 Bettlach Switzerland
55 additional Subsidiary records available in full report.

Business Names
Business Name
360 EPPA Pty Ltd
360 Hip Systems Pty Limited
360 Knee Systems (NZ) Limited
130 additional Business Names available in full report.

General Information
Number of Employees: 6,550 (As of 12/31/2023)
Outstanding Shares: 54,619,822 (As of 2/16/2024)
Shareholders: 1,267
Stock Exchange: NYSE
Federal Tax Id: 541887631
Fax Number: (301) 323-9001


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Thursday, March 28, 2024